Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Meikle

Showing results (1-10 of 322) with videos related to

Pageof 33
Sort By:
Nature Reviews. Cardiology|September 2, 2025
Building the Australian Cardiovascular disease Data CommonsCorey Giles, Peter J Meikle
European Journal of Pediatrics|November 12, 2003
Lysosomal storage disorders: emerging therapeutic options require early diagnosisPeter J Meikle, John J Hopwood
Nature Reviews. Endocrinology|November 4, 2016
Sphingolipids and phospholipids in insulin resistance and related metabolic disordersPeter J Meikle, Scott A Summers
Current Opinion in Lipidology|March 8, 2011
Lipidomics is providing new insight into the metabolic syndrome and its sequelaePeter J Meikle, Michael J Christopher
Clinical Lipidology|September 28, 2020
New approaches for the discovery of lipid‑related genesJoanne E Curran, Peter J Meikle, John Blangero
Pharmacology & Therapeutics|May 20, 2026
Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular riskM John Chapman, Patrice Therond, Peter J Meikle
European Heart Journal|May 19, 2017
Platelet lipidomics: a window of opportunity to assess cardiovascular risk?James D McFadyen, Peter J Meikle, Karlheinz Peter
Progress in Lipid Research|August 24, 2019
WITHDRAWN: Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic diseaseSudip Paul, Graeme I Lancaster, Peter J Meikle
Islets|August 1, 2012
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunctionEbru Boslem, Peter J Meikle, Trevor J Biden
Progress in Lipid Research|April 12, 2019
Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic diseaseSudip Paul, Graeme I Lancaster, Peter J Meikle
Pageof 33

Showing results (1-10 of 322) with videos related to

Sort By:
Pageof 33
Nature Reviews. Cardiology|September 2, 2025
Building the Australian Cardiovascular disease Data CommonsCorey Giles, Peter J Meikle
European Journal of Pediatrics|November 12, 2003
Lysosomal storage disorders: emerging therapeutic options require early diagnosisPeter J Meikle, John J Hopwood
Nature Reviews. Endocrinology|November 4, 2016
Sphingolipids and phospholipids in insulin resistance and related metabolic disordersPeter J Meikle, Scott A Summers
Current Opinion in Lipidology|March 8, 2011
Lipidomics is providing new insight into the metabolic syndrome and its sequelaePeter J Meikle, Michael J Christopher
Clinical Lipidology|September 28, 2020
New approaches for the discovery of lipid‑related genesJoanne E Curran, Peter J Meikle, John Blangero
Pharmacology & Therapeutics|May 20, 2026
Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular riskM John Chapman, Patrice Therond, Peter J Meikle
European Heart Journal|May 19, 2017
Platelet lipidomics: a window of opportunity to assess cardiovascular risk?James D McFadyen, Peter J Meikle, Karlheinz Peter
Progress in Lipid Research|August 24, 2019
WITHDRAWN: Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic diseaseSudip Paul, Graeme I Lancaster, Peter J Meikle
Islets|August 1, 2012
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunctionEbru Boslem, Peter J Meikle, Trevor J Biden
Progress in Lipid Research|April 12, 2019
Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic diseaseSudip Paul, Graeme I Lancaster, Peter J Meikle
Pageof 33